MAPT and tauopathy: Our findings demonstrated remarkably sexual dimorphism in the behavior, neuropathology, and biomarkers in tau P301S transgenic mice and indicated that the use of male P301S transgenic mice may be more suitable for assessing anti-phosphorylated tau therapeutic strategies for AD and related tauopathies.